ObjectiveTo investigate the research status of remdesivir for coronavirus by bibliometrics method. MethodsThe literature concerning coronavirus treated by remdesivir were searched in the Chinese database of CNKI, Wang Fang Data, CBM, and the English database of Pubmed, Web of Science, Ovid, and Embase from database construction to March 2020. Bibliometrics analysis was performed on the literature enrolled to the research. ResultsSeventeen literature was enrolled in the research, of which 4 literature belonged to clinical research (23.53%) and 13 to basic research (76.47%). Most of the literature was published in the United States and England, which were related research accomplished together by various research institutes, and their researchers were mainly from the United State and Canada; moreover, the organization in which the first authors affiliated to were mostly colleges and scientific institutes, and with more than 10 participating authors in most of the studies; furthermore, most of the studies (82.35%) received funding. The preferable high-frequency keywords presented as remdesivir, GS-5734, coronavirus, Ebola virus, SARS-CoV, MERS-CoV, RdRp, and RNA polymerases in the enrolled literature. ConclusionThe research of remdesivir for coronavirus dates from the past 5 years. The amount of literature is small, most of which are basic research, but with few clinical research. Most of the research is accomplished in developed countries like Europe and America.

无